Cargando…
A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy
INTRODUCTION: The prognosis of adrenal metastasis from non‐small cell lung cancer is very poor. A recent report described the efficacy of the surgical removal of adrenal metastasis when solitary. However, metachronous bilateral adrenal metastasis is extremely rare, and a treatment strategy has not b...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626332/ https://www.ncbi.nlm.nih.gov/pubmed/36341191 http://dx.doi.org/10.1002/iju5.12519 |
_version_ | 1784822706865176576 |
---|---|
author | Tomiyama, Nami Naiki, Taku Naiki‐Ito, Aya Kawai, Tatsuya Etani, Toshiki Gonda, Masakazu Aoki, Maria Morikawa, Toshiharu Sugiyama, Yosuke Yasui, Takahiro |
author_facet | Tomiyama, Nami Naiki, Taku Naiki‐Ito, Aya Kawai, Tatsuya Etani, Toshiki Gonda, Masakazu Aoki, Maria Morikawa, Toshiharu Sugiyama, Yosuke Yasui, Takahiro |
author_sort | Tomiyama, Nami |
collection | PubMed |
description | INTRODUCTION: The prognosis of adrenal metastasis from non‐small cell lung cancer is very poor. A recent report described the efficacy of the surgical removal of adrenal metastasis when solitary. However, metachronous bilateral adrenal metastasis is extremely rare, and a treatment strategy has not been established. CASE PRESENTATION: Herein, we describe a 52‐year‐old Asian male who presented with a right adrenal metastasis of non‐small cell lung cancer 8 months after immunochemotherapy and surgical resection of the lung. He underwent combined systemic treatment and a laparoscopic right adrenalectomy; however, after 9 months, a metachronous left adrenal metastasis emerged. A subsequent laparoscopic left adrenalectomy and systemic treatment led to long‐term progression‐free survival. CONCLUSION: The appropriate surgical indication and combined systemic treatment of a metachronous bilateral adrenal metastasis in non‐small cell lung cancer may extend the prognosis. |
format | Online Article Text |
id | pubmed-9626332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96263322022-11-03 A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy Tomiyama, Nami Naiki, Taku Naiki‐Ito, Aya Kawai, Tatsuya Etani, Toshiki Gonda, Masakazu Aoki, Maria Morikawa, Toshiharu Sugiyama, Yosuke Yasui, Takahiro IJU Case Rep Case Reports INTRODUCTION: The prognosis of adrenal metastasis from non‐small cell lung cancer is very poor. A recent report described the efficacy of the surgical removal of adrenal metastasis when solitary. However, metachronous bilateral adrenal metastasis is extremely rare, and a treatment strategy has not been established. CASE PRESENTATION: Herein, we describe a 52‐year‐old Asian male who presented with a right adrenal metastasis of non‐small cell lung cancer 8 months after immunochemotherapy and surgical resection of the lung. He underwent combined systemic treatment and a laparoscopic right adrenalectomy; however, after 9 months, a metachronous left adrenal metastasis emerged. A subsequent laparoscopic left adrenalectomy and systemic treatment led to long‐term progression‐free survival. CONCLUSION: The appropriate surgical indication and combined systemic treatment of a metachronous bilateral adrenal metastasis in non‐small cell lung cancer may extend the prognosis. John Wiley and Sons Inc. 2022-08-02 /pmc/articles/PMC9626332/ /pubmed/36341191 http://dx.doi.org/10.1002/iju5.12519 Text en © 2022 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Case Reports Tomiyama, Nami Naiki, Taku Naiki‐Ito, Aya Kawai, Tatsuya Etani, Toshiki Gonda, Masakazu Aoki, Maria Morikawa, Toshiharu Sugiyama, Yosuke Yasui, Takahiro A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy |
title | A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy |
title_full | A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy |
title_fullStr | A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy |
title_full_unstemmed | A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy |
title_short | A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy |
title_sort | rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626332/ https://www.ncbi.nlm.nih.gov/pubmed/36341191 http://dx.doi.org/10.1002/iju5.12519 |
work_keys_str_mv | AT tomiyamanami ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT naikitaku ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT naikiitoaya ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT kawaitatsuya ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT etanitoshiki ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT gondamasakazu ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT aokimaria ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT morikawatoshiharu ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT sugiyamayosuke ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT yasuitakahiro ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT tomiyamanami rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT naikitaku rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT naikiitoaya rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT kawaitatsuya rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT etanitoshiki rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT gondamasakazu rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT aokimaria rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT morikawatoshiharu rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT sugiyamayosuke rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy AT yasuitakahiro rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy |